-
Posted by
Two Blokes Jul 28 -
Filed in
Stock
-
2 views
Celcuity said on Monday its experimental combination treatment delayed the progression of a type of advanced breast cancer, sending the biotech firm's shares surging more than twofold in premarket trading.
